CVS Health Corp (NYSE: CVS) shares are trading higher by 3.97% at $99.79 after the company reported better-than-expected first-quarter EPS and sales results. The company also raised its FY22 EPS guidance.
CVS Health reported quarterly earnings of $2.22 per share which beat the analyst …
Full story available on Benzinga.com